Cargando…

Prognostic value and outcome for acute lymphocytic leukemia in children with MLL rearrangement: a case-control study

PURPOSE: To evaluate the prognostic factors and outcome for acute lymphoblastic leukemia (ALL) in children with MLL rearrangement (MLL-r). METHODS: A total of 124 pediatric patients who were diagnosed with ALL were classified into two groups based on the MLL-r status by using a retrospective case-co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Kun-yin, Zhou, Dun-hua, Liao, Xiong-yu, Huang, Ke, Li, Yang, Xu, Hong-gui, Weng, Wen-jun, Xu, Lu-hong, Fang, Jian-pei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719147/ https://www.ncbi.nlm.nih.gov/pubmed/36461002 http://dx.doi.org/10.1186/s12885-022-10378-w

Ejemplares similares

Coexistence of ETV6-RUNX1 and MLL aberration among pediatric acute lymphoblastic leukemia: case reports and a literature review
por: Qiu, Kun-Yin, et al.
Publicado: (2023)

MLL leukemia-associated rearrangements in peripheral blood lymphocytes from healthy individuals
por: Brassesco, María Sol, et al.
Publicado: (2009)

RNA binding proteins in MLL-rearranged leukemia
por: Tran, Tiffany M., et al.
Publicado: (2022)

Ruxolitinib inhibits the proliferation and induces the apoptosis of MLL-r ALL cells through inactivating JAK/STAT signaling pathway
por: Liao, Xiong-Yu, et al.
Publicado: (2023)

MLL-Rearranged Leukemias—An Update on Science and Clinical Approaches
por: Winters, Amanda C., et al.
Publicado: (2017)

Preferential induction of MLL(Mixed Lineage Leukemia) rearrangements in human lymphocyte cultures treated with etoposide
por: Brassesco, María Sol, et al.
Publicado: (2009)

MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
por: Zangrando, Andrea, et al.
Publicado: (2009)

Identification of Genes Transcriptionally Responsive to the Loss of MLL Fusions in MLL-Rearranged Acute Lymphoblastic Leukemia
por: van der Linden, Marieke H., et al.
Publicado: (2015)

Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
por: Feng, Zizhen, et al.
Publicado: (2016)

The landscape of somatic mutations in Infant MLL rearranged acute lymphoblastic leukemias
por: Andersson, Anna K, et al.
Publicado: (2015)

Outcome and prognostic factors of CBF pediatric AML patients with t(8;21) differ from patients with inv(16)
por: Qiu, Kun-yin, et al.
Publicado: (2023)

Replication stress in MLL-rearrangements
por: Milyavsky, Michael, et al.
Publicado: (2015)

The developmental stage of the hematopoietic niche regulates lineage in MLL-rearranged leukemia
por: Rowe, R. Grant, et al.
Publicado: (2019)

Rationale for targeting BCL6 in MLL-rearranged acute lymphoblastic leukemia
por: Hurtz, Christian, et al.
Publicado: (2019)

Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
por: Brzezinka, Krzysztof, et al.
Publicado: (2019)

ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia
por: Wang, Yungui, et al.
Publicado: (2017)

DNA index as prognostic factor in childhood acute lymphoblastic leukemia in the COG-TARGET database
por: Qiu, Kun-yin, et al.
Publicado: (2021)

FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML
por: Sheng, Yue, et al.
Publicado: (2020)

Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair
por: Ye, Jing, et al.
Publicado: (2019)

Erratum: Replication stress in MLL-rearrangements
por: Milyavsky, Michael, et al.
Publicado: (2016)

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
por: Zhu, Xiao-Na, et al.
Publicado: (2023)

ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia
por: Germano, Giuseppe, et al.
Publicado: (2017)

Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
por: Chan, Anthony K. N., et al.
Publicado: (2019)

Perturbation of Methionine/S-adenosylmethionine Metabolism as a Novel Vulnerability in MLL Rearranged Leukemia
por: Barve, Aditya, et al.
Publicado: (2019)

Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia
por: Oliveira, Tiago, et al.
Publicado: (2021)

PROM1 and CTGF Expression in Childhood MLL-Rearrangement Acute Lymphoblastic Leukemia
por: Wang, Lu-lu, et al.
Publicado: (2022)

Uncovering NOTCH1 as a Promising Target in the Treatment of MLL-Rearranged Leukemia
por: Fischer, Jacqueline, et al.
Publicado: (2023)

Transcription factor MEF2D is required for the maintenance of MLL-rearranged acute myeloid leukemia
por: Zhao, Lianzhong, et al.
Publicado: (2021)

Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency
por: Muñoz-López, Alvaro, et al.
Publicado: (2016)

KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements
por: Au, Yan Zi, et al.
Publicado: (2021)

MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia
por: Itskovich, Svetlana S., et al.
Publicado: (2020)

The “Never-Ending” Mouse Models for MLL-Rearranged Acute Leukemia Are Still Teaching Us
por: Ottersbach, Katrin, et al.
Publicado: (2018)

Identification of co-expressed genes associated with MLL rearrangement in pediatric acute lymphoblastic leukemia
por: Zhang, Hao, et al.
Publicado: (2020)

Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)—Gene Rearrangements
por: Tsakaneli, Alexia, et al.
Publicado: (2021)

Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience
por: Richard-Carpentier, Guillaume, et al.
Publicado: (2021)

Jiyuan Oridonin A Overcomes Differentiation Blockade in Acute Myeloid Leukemia Cells With MLL Rearrangements via Multiple Signaling Pathways
por: Qu, Mei, et al.
Publicado: (2021)

Development of a Multi-Step Leukemogenesis Model of MLL-Rearranged Leukemia Using Humanized Mice
por: Moriya, Kunihiko, et al.
Publicado: (2012)

Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemia
por: Chen, Lili, et al.
Publicado: (2016)

Decitabine demonstrates antileukemic activity in B cell precursor acute lymphoblastic leukemia with MLL rearrangements
por: Roolf, C., et al.
Publicado: (2018)

Identification of hub genes and molecular mechanisms in infant acute lymphoblastic leukemia with MLL gene rearrangement
por: Zhang, Hao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6f4o1u7k8bg4ksb51vu7vc782n